Stay updated on OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial

Sign up to get notified when there's something new on the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov page now displays site revision v3.8.0 instead of v3.7.2.
    Difference
    0.1%
    Check dated 2026-11-01T01:55:23.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a transition to using “Super Intelligence” instead of “Artificial Intelligence” in federal agency content.
    Difference
    0.7%
    Check dated 2026-10-25T01:51:20.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    The site revision shown in the footer changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-18T01:36:38.000Z thumbnail image
  4. Check
    27 days ago
    Change Detected
    Summary
    The site footer revision changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-11T02:08:33.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page history now includes a new revision entry for v3.7.0 and removes the previous v3.6.6 entry, signaling an updated version of the page's metadata in the study record history.
    Difference
    0.1%
    Check dated 2026-09-20T00:48:00.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    A new revision entry v3.6.6 was added to the study record history, and the previous entry v3.6.5 was removed. This updates the page's version history to reflect the latest revision.
    Difference
    0.1%
    Check dated 2026-08-29T21:54:20.000Z thumbnail image

Stay in the know with updates to OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial

Enter your email address, and we'll notify you when there's something new on the OptiPOM: Alternate Day Pomalidomide in Refractory MM Clinical Trial page.